Cancer and Genomics, Ph.D.

Entry Points: September, January, April, July Our Cancer and Genomics PhD programme is available on a full-time or part-time basis, over 3 or 6 years. Cancer will affect half the population in the UK in the coming years, with many of those still dying of the disease because of late presentation and lack of therapeutic options. Hence, Medical School researchers are actively studying this disease to better understand mechanisms, develop better diagnostic markers and develop novel therapeutic avenues to improve patient outcomes.

Your programme will feature: Practice-focused learning Supervision team with nominated supervisors You will draw on skills from the broader academic community Programme seminars and workshops Access to Wales’ premier purpose-build medical research facility Collaboration with industry and business partners During your course, you will benefit from our highly regarded specialist facilities. Our vision is to advance medical science through interdisciplinary research and innovation. We are a leading centre for medical research and a unique example of successful collaboration between NHS, academia and industry in the life science and health sector.

We have strong connections with a range of external partners and collaborators, including the NHS; Swansea Bay University Health Board (SBUHB) ; Hywel Dda University Health Board ; UK research council; Welsh Government and numerous national and international links. These connections, along with the skills and qualities you develop during your research degree will enhance your CV, and help you stand out in a highly competitive graduate employment market.